US5324571083
US5324571083
Eli Lilly and Company
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 70/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).
Beta (Market Relation)
0.45x
DefensiveVolatility (5Y p.a.)
32.7% p.a.
5-Year HorizonMax Drawdown (5Y)
-34.8%
5-Year HorizonSharpe Ratio
1.09
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y) High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +38.3% |
| 3 Years | 35.5% | -34.8% | 0.69 | +26.9% |
| 5 Years | 32.7% | -34.8% | 1.09 | +38% |
| 10 Years | 30.6% | -34.8% | 0.91 | +30.3% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.7% p.a.).
Corporate Governance & ISS Scores
Overall Governance Risk
8 ISS Score: 8 / 10
Audit Risk
8 ISS Score: 8 / 10
Board Risk
5 ISS Score: 5 / 10
Short Ratio
3.09